PURPOSE:
Microcrystalline cellulose (MCC) from domestic plant materials (flax and hemp) is intended for the production of solid dosage forms in the pharmaceutical industry as an alternative to the imported more expensive MCC from softwood and cotton.
DESCRIPTION:
Domestic pharmaceutical companies annually purchase tens of tons of imported MCC. The production of MCC from domestic plant materials partially solves the problem of import substitution, reduces the cost of final products by 20-30%, increases the competitiveness of the production of domestic medicinal tablets.
ADVANTAGES:
MCC from domestic plant materials meets the best foreign analogues and the requirements of domestic and European pharmacopeia.
RESULTS OF THE RESEARCH:
Ready for implementation.
STAGE OF THE DEVELOPMENT READINESS:
Ready for implementation.
TRANSFER OPPORTUNITY:
License sales.
NOVELTY:
1 patent of Ukraine.
IF YOU ARE INTERESTED IN THIS DEVELOPMENT, PLEASE,
WRITE TO US